# Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer

> **NCT00003860** · PHASE2 · COMPLETED · sponsor: **UNICANCER** · enrollment: 36 (estimated)

## Conditions studied

- Lung Cancer

## Interventions

- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** etoposide
- **DRUG:** ifosfamide
- **PROCEDURE:** in vitro-treated peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00003860
- **Lead sponsor:** UNICANCER
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** 2000-08
- **Final completion:** 2005-09
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2021-02-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00003860

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00003860, "Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00003860. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*